NORTH
CHICAGO, Ill., June 6, 2023
/PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Goldman
Sachs 44th Annual Global Healthcare Conference on Wednesday, June 14, 2023. Robert A. Michael, vice chairman and president,
Jeffrey R. Stewart, executive vice
president, chief commercial officer and Roopal Thakkar, senior vice president,
development and regulatory affairs and chief medical officer, will
present at 10:00 a.m. Central
time.
A live audio webcast of the presentation will be accessible
through AbbVie's Investor Relations website at
investors.abbvie.com. An archived edition of the session will be
available later that day.
About AbbVie
AbbVie's mission is to discover and deliver innovative medicines
that solve serious health issues today and address the medical
challenges of tomorrow. We strive to have a remarkable impact on
people's lives across several key therapeutic areas: immunology,
oncology, neuroscience, eye care, virology and gastroenterology, in
addition to products and services across our Allergan Aesthetics
portfolio. For more information about AbbVie, please visit us at
www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram,
YouTube and LinkedIn.
View original
content:https://www.prnewswire.com/news-releases/abbvie-to-present-at-the-goldman-sachs-44th-annual-global-healthcare-conference-301837200.html
SOURCE AbbVie